For the fourth annual edition of Canadian Business's flagship awards, we narrowed in on companies fighting the climate crisis ...
EPYSQLI ® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback